In addition, miR-20 targets CDKN1A (P21), an important negative regulator of cell cycle progression activated by TGFβ in colorectal cancer cells and blocks TGFβ-induced antiproliferative effect (35). The gene discussed is TGFB1; the disease is colorectal cancer.